Prevention of hepatitis A with the hepatitis A vaccine.
نویسندگان
چکیده
From the Communicable and Environmental Disease Services Section, Tennessee Department of Health (A.S.C.); and the Department of Preventive Medicine, Vanderbilt University School of Medicine (W.S.) — both in Nashville. Address reprint requests to Dr. Schaffner at the Department of Preventive Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232, or at [email protected].
منابع مشابه
DNA-Based Vaccine Is More Efficient than Non-Pathogenic Live Vaccine for the Prevention of HPV16 E7-Overexpressing Cancers
Introduction: Vaccinology provides promising approaches for the control of various infectious diseases. Among different strategies, DNA vaccines offer attractive research opportunities for development of vaccines for induction of antigen-specific immunity owing to their stability, simplicity of delivery, safety and cost effectiveness. However, there is a need to increase their potency by the ...
متن کاملExpression of S and pre s2 Hepatitis B Surface Antigens in Mammalian Cos-7 Cell Line
Hepatitis B virus (HBV) is a serious global health problem. The development of a safe and effective vaccinewould help infection prevention. Previous hepatitis B vaccine production involved the isolation of the noninfectious particle from chronic HBV carriers. DNA recombinant technology has been used for vaccineproduction without having been contaminated with blood-born infectious ag...
متن کاملPolymer-basednanoadjuvants for hepatitis C vaccine: The perspectives of immunologists
The hepatitis C virus (HCV) is an infection that affects the liver tissues in humans, leading to the development of effective prophylactic and therapeutic HCV vaccines to prevent a global epidemic. Scientists consider it challenging to produce a therapeutic vaccine for the treatment of hepatocellular carcinoma as opposed to a preventative vaccine. However, several drawbacks are involved with a ...
متن کاملهپاتیت ویروسی و پیشگیری از آن وضعیت موجود با نگاهی به آینده
Viral hepatitis is the most common cause of liver disease in the world. In the past 30 years, highly effective vaccines have become available for two of the five hepatitis viruses, and where implemented, vaccination has become a key component of hepatitis prevention. To provide a current review and critical analysis of the viral hepatitis, A (HAV) and B (HBV) prevention by immunization has be...
متن کاملHepatitis B vaccine immunogenicity in Kerman 12 months infants
Introduction: Infection with HBV is the most common chronic viral infection and mortality in children. Prevention of this infection with vaccination is vital. This study was done to compare the antibody level in post hepatitis B vaccination in children with 12 months age. Materials and Methods:This descriptive study was carreid out on healthy 120 children ...
متن کاملSTUDY ON THE EF FICACY OF RECOMBINANT HEPATITIS B VACCINE IN IRANIAN INFANTS
In order to determine the efficacy of recombinant hepatitis B vaccine in Iranian infants, we analyzed the efficacy of a recombinant hepatitis B vaccine in 115 infants aged 12-24 months born to HBsAg negative mothers who received three doses of HBV Antibody to hepatitis B surface antigen (anti-HBs) was checked after the third dose of the vaccine, 94.8% of the infants had developed protective...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- The New England journal of medicine
دوره 350 5 شماره
صفحات -
تاریخ انتشار 2004